Mesothelioma and Asbestos

A research team from Oxford University developed a recent diagnostic test for mesothelioma, a rare form of cancer that is caused by asbestos exposure. This recent test looks at levels of a protein called meothelin in patients’ pleural fluid – fluid found in the pleural cavity surrounding the lungs.

Currently, doctors take a diagnostic test called pleural fluid cytology, a lab test that looks for cancer cells, but the test isn’t very sensitive. By looking at the pleural fluid samples from more than 200 patients of a respiratory clinic, researchers found that mesothelioma patients had meothelin levels that were six times higher than patients with secondary lung cancers as well as 10 times higher than patients with benign conditions.

Using the meothelin test, clinicians will be capable to identify as well as diagnose mesothelioma patients earlier, reducing the number of invasive tests as well as procedures they need, as well as requiring less time in the hospital. Chemotherapy, radiation therapy, as well as symptom relief can begin sooner with an earlier diagnosis, as well as worker’s compensation claims can be initiated once the diagnosis has been confirmed.

For the filled story, go to BBC News.